Skip to main content
Toggle navigation
Login
Search
Home
Preview Program
Poster Schedule
Home
Poster Schedule
All Days
Fri, Apr 24
Sat, Apr 25
Poster Schedule
Type here to filter the list
Friday, April 24, 2026
9:45 AM - 1:30 PM
PT
(1) Successful Implementation of HCV Point-of-Care Testing in a Syringe Services Program
Favorite
9:45 AM - 1:30 PM
PT
(2) PrEP Eligibility Among People Who Use Drugs Accessing Opioid Treatment Programs
Favorite
9:45 AM - 1:30 PM
PT
(3) HIV/PrEP Knowledge, Perceived Risk, and Attitudes Among PWID After a Hospital Intervention
Favorite
9:45 AM - 1:30 PM
PT
(4) Optimizing Geographic Naloxone Distribution to Reduce Opioid Overdose Deaths
Favorite
9:45 AM - 1:30 PM
PT
(5) EMS-Attended Overdoses Before and After the COVID-19 Pandemic in Camden, New Jersey
Favorite
9:45 AM - 1:30 PM
PT
(6) Perceptions of Harm Reduction Integration in Treatment: A Qualitative Study
Favorite
9:45 AM - 1:30 PM
PT
(7) Stigma and Treatment Engagement in Addiction Medicine: Pilot Findings Across Stigma Domains
Favorite
9:45 AM - 1:30 PM
PT
(8) Naloxone Vending at Jail Release Works Without Mandatory Overdose Education
Favorite
9:45 AM - 1:30 PM
PT
(9) Determinants of Naloxone Favorability and Carrying in the General Public
Favorite
9:45 AM - 1:30 PM
PT
(10) Patient-Centered Design: Improving Naloxone Access Through Patient Insights
Favorite
9:45 AM - 1:30 PM
PT
(11) Pre-EMS Naloxone Administrator Role and Predictors of Receiving Subsequent Naloxone by EMS
Favorite
9:45 AM - 1:30 PM
PT
(12) Real-World Analysis of Buprenorphine-Precipitated Opioid Withdrawal: A Multicenter Study
Favorite
9:45 AM - 1:30 PM
PT
(13) Addiction-Informed Opioid-Sparing Pain Care in the ED: ED-ALT Outcomes
Favorite
9:45 AM - 1:30 PM
PT
(14) OPRD1 rs678849 Predicts Buprenorphine Outcomes in an ED-Initiated MOUD Program
Favorite
9:45 AM - 1:30 PM
PT
(15) Extracting Post-Opioid Overdose Care from ED Encounters Using Large Language Models
Favorite
9:45 AM - 1:30 PM
PT
(16) Self-Reported Effects Associated With Xylazine/Medetomidine in Drug Checking Samples
Favorite
9:45 AM - 1:30 PM
PT
(17) Xylazine-Adulterated Fentanyl in Pregnancy: Postpartum Withdrawal With GI Hemorrhage
Favorite
9:45 AM - 1:30 PM
PT
(18) Xylazine in the Fentanyl Era: Patient Perspectives on Methadone and Emergency Care
Favorite
9:45 AM - 1:30 PM
PT
(19) Maternal and Fetal Effects Associated With Perinatal Xylazine Exposure: A Systematic Review
Favorite
9:45 AM - 1:30 PM
PT
(20) Methadone as Treatment for Tianeptine Withdrawal
Favorite
9:45 AM - 1:30 PM
PT
(21) Tianeptine Misuse: Systematic Review of Clinical Features, Withdrawal, and Management
Favorite
9:45 AM - 1:30 PM
PT
(22) Recovery is WORTH IT: Data from a Statewide Low-Threshold Buprenorphine Telehealth Program
Favorite
9:45 AM - 1:30 PM
PT
(23) Impact of Implementation Strategies on Collaboration Between Drug Courts and MOUD Providers
Favorite
9:45 AM - 1:30 PM
PT
(24) Impact of MOUD on Mental Health and Counseling Services in Jails
Favorite
9:45 AM - 1:30 PM
PT
(25) Buh-Bylazine! Xylazine Positivity Rate Change Among Patients in a Low-Barrier Access Clinic
Favorite
9:45 AM - 1:30 PM
PT
(26) Overcoming Barriers to Outpatient Buprenorphine Treatment for Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(27) Perceptions of Psilocybin Assisted Therapy (PAT) for Substance Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(28) Inpatient Discharge Prescribing and Early Engagement Predict Buprenorphine Continuation
Favorite
9:45 AM - 1:30 PM
PT
(29) Buprenorphine Dose and Pain Outcomes in Opioid Use Disorder and Chronic Pain
Favorite
9:45 AM - 1:30 PM
PT
(30) Barriers Persist: MOUD Knowledge, Attitudes, & Prescribing in North Carolina Family Medicine
Favorite
9:45 AM - 1:30 PM
PT
(31) An Open Label Pilot RCT of Low- vs High-Dose Telemedicine Buprenorphine Initiation
Favorite
9:45 AM - 1:30 PM
PT
(32) AI-Standardized Patient Reveals Practice Gaps After REMS-Aligned OUD Training
Favorite
9:45 AM - 1:30 PM
PT
(33) Characteristics of Pregnant Individuals Receiving Long-Acting Injectable Buprenorphine
Favorite
9:45 AM - 1:30 PM
PT
(34) Opioid Use Disorder Treatment Model: Access to Healthcare Barrier Survey
Favorite
9:45 AM - 1:30 PM
PT
(35) Assessing the Effects of Sublingual Buprenorphine on Dental Caries
Favorite
9:45 AM - 1:30 PM
PT
(36) Human Laboratory Evaluation of Direct-to-Inject XR-Buprenorphine: Preliminary Results
Favorite
9:45 AM - 1:30 PM
PT
(37) Advancing Access to Long-Acting Injectable Buprenorphine Through Community Pharmacies
Favorite
9:45 AM - 1:30 PM
PT
(38) Co-Located Bridge Clinic/Withdrawal Management Unit Reduces 30-Day Readmits Using LA-Bup Injections
Favorite
9:45 AM - 1:30 PM
PT
(39) High Retention Over 24 Months in Telehealth-Only Buprenorphine Program
Favorite
9:45 AM - 1:30 PM
PT
(40) Successful Buprenorphine Microinduction in Patient With Severe Kratom (7-OH) Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(41) Kratom Use in ADHD: A Case Highlighting Stimulant and Injectable-Buprenorphine Initiation
Favorite
9:45 AM - 1:30 PM
PT
(42) A Case of Baclofen-Managed Phenibut Dependence With Concurrent Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(43) Stigma as a Barrier to Early Retention in MOUD Treatment
Favorite
9:45 AM - 1:30 PM
PT
(44) Initiating Methadone for the Incarcerated: Implementation at Allegheny County Jail
Favorite
9:45 AM - 1:30 PM
PT
(45) Rapid Methadone Titration Protocols in Opioid Use Disorder: A Systematic Review
Favorite
9:45 AM - 1:30 PM
PT
(46) QTc Prolongation of Slow-Release Oral Morphine vs Methadone for Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(47) Risk Reduction in Methadone Clinics: Addressing the Complexities of Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(48) Accelerating Access: A Rapid Methadone Protocol for Outpatient Care
Favorite
9:45 AM - 1:30 PM
PT
(49) Patient Experiences With a Low-Threshold Mobile Medical Unit for Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(50) Real-World Healthcare Utilization With SROM Versus Methadone: A Target Trial Emulation
Favorite
9:45 AM - 1:30 PM
PT
(51) Effectiveness and Key Components of Recovery Communities: A Rapid Review
Favorite
9:45 AM - 1:30 PM
PT
(52) Addiction Treatment Program Quality Measures: Results of a NIDA-Funded Study
Favorite
9:45 AM - 1:30 PM
PT
(53) Impact of OAT in Individuals With OUD Who Experienced Overdose in Ontario
Favorite
9:45 AM - 1:30 PM
PT
(54) Current Practice Patterns for Treating Alcohol Use Disorder in US Emergency Departments
Favorite
9:45 AM - 1:30 PM
PT
(55) Increased Naltrexone Prescribed for Alcohol Use After Changes to Obesity Treatment Protocol
Favorite
9:45 AM - 1:30 PM
PT
(56) Expanding Screening and Treatment for Alcohol Use Disorder for Undocumented Latinx Patients
Favorite
9:45 AM - 1:30 PM
PT
(57) Confluence of Discrimination and Belongingness in LGBTQ+ Substance Use
Favorite
9:45 AM - 1:30 PM
PT
(58) Denied at the Door: Accessibility of Substance Use Treatment Facilities
Favorite
9:45 AM - 1:30 PM
PT
(59) Disability Rights Training for Peer Support Specialists: A Prospective Survey Study
Favorite
9:45 AM - 1:30 PM
PT
(60) Substance Use Among Adolescents in Pediatric Primary Care
Favorite
9:45 AM - 1:30 PM
PT
(61) New Extremely High Urine Cotinine Levels in Adolescents Who Vape Nicotine
Favorite
9:45 AM - 1:30 PM
PT
(62) Comorbidities and Mortality in Substance Use Disorder Patients With Nicotine Dependence
Favorite
9:45 AM - 1:30 PM
PT
(63) No Better Time Than the Present: Helping Hospitalized Veterans Quit Smoking
Favorite
9:45 AM - 1:30 PM
PT
(64) Local Policy Matters: Structural Violence, Vaping, and Immigrant-Inclusive Protections
Favorite
9:45 AM - 1:30 PM
PT
(65) Tobacco-Stimulant Co-Use Among US Adults: National Trends and Persistent Role of Tobacco
Favorite
9:45 AM - 1:30 PM
PT
(66) Mixed-Methods Contingency Management for Smoking in Perinatal Opioid Use Disorder
Favorite
9:45 AM - 1:30 PM
PT
(67) Impact of Contingency Management on Retention in Outpatient SUD Programs
Favorite
9:45 AM - 1:30 PM
PT
(68) Mobilizing Contingency Management for Stimulant Use Disorder in the Street Medicine Setting
Favorite
9:45 AM - 1:30 PM
PT
(69) Contingency Management in Community Primary Care: An Essential and Successful Integration
Favorite
9:45 AM - 1:30 PM
PT
(70) Ketamine for Co-Cccurring Major Depressive and Alcohol Use Disorders: A Systematic Review
Favorite
9:45 AM - 1:30 PM
PT
(71) High Completion and Patient Satisfaction in a Virtual Ambulatory Alcohol Detox Program
Favorite
9:45 AM - 1:30 PM
PT
(72) Ketamine Effects on Anxiety and Drug Seeking Behaviors in Methamphetamine-Withdrawn Rats
Favorite
9:45 AM - 1:30 PM
PT
(73) Prenatal Methamphetamine Exposure and Intracranial Hemorrhage in Infants
Favorite
9:45 AM - 1:30 PM
PT
(74) Sensory Processing Sensitivity and Substance Use Disorder: A Multidimensional Exploration
Favorite
9:45 AM - 1:30 PM
PT
(75) Advancing Clinician-Informed, Symptom-Specific Approaches to Opioid Withdrawal Care
Favorite
9:45 AM - 1:30 PM
PT
(76) Bridging the Divide: A Telemedicine Bridge Clinic Improves Access to OUD Care
Favorite
9:45 AM - 1:30 PM
PT
(77) Increased Healthcare Utilization and Acuity Associated With Medetomidine
Favorite
9:45 AM - 1:30 PM
PT
(78) Relations Between Cannabis Craving, Distress Intolerance, And Coping Motives: A Pilot Study
Favorite
9:45 AM - 1:30 PM
PT
(79) Disparities in Adolescent Cannabis Treatment Admissions by the Criminal Justice System
Favorite
9:45 AM - 1:30 PM
PT
(80) SBIRT Model to Combine Direct Early Intervention and mHealth for Substance-Involved Youth
Favorite
9:45 AM - 1:30 PM
PT
(81) Screening, Brief Intervention, and Referral to Treatment Dose Effects in Foster Youth
Favorite
9:45 AM - 1:30 PM
PT
(82) The Relationship Between Problematic Internet Use and Substance Use in Adolescents
Favorite
9:45 AM - 1:30 PM
PT
(83) Polysubstance Use Among New York Transition-Age Adults Who Use Opioids, 2018–2024
Favorite
9:45 AM - 1:30 PM
PT
(84) An Educational Intervention to Improve Trainee Confidence in Managing Opioid Withdrawal
Favorite
9:45 AM - 1:30 PM
PT
(85) Treatment First: Early Trends in Use of Opioid Settlement Funds Across USA
Favorite
9:45 AM - 1:30 PM
PT
(86) Health Claims and Marketing Practices in the Online Kratom Marketplace
Favorite
9:45 AM - 1:30 PM
PT
(87) Relationship Conflict Reduces Recovery Capital: Oregon 2SLGBTQIA+ Community Findings
Favorite
9:45 AM - 1:30 PM
PT
(89) Participant Perspectives of a Peer Recovery-Enhanced Jail MAT Program
Favorite
9:45 AM - 1:30 PM
PT
(90) Opioid Management Review Committee Enhances Addiction Competencies in Palliative Care
Favorite
9:45 AM - 1:30 PM
PT
(91) Written Exposure Therapy for PTSD Increases Recovery Capital for Adults With SUD
Favorite
9:45 AM - 1:30 PM
PT
(92) Reducing Hospital Costs and Improving Access to Care With Hotel Vouchers
Favorite
9:45 AM - 1:30 PM
PT
(93) Words Matter: Results of a Stigma Reduction Initiative in a Safety-Net System
Favorite
9:45 AM - 1:30 PM
PT
(94) When Hot Flashes Are Not Withdrawal: Perimenopause in Opioid Use Disorder
Favorite
